Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Number of holders
-
891
-
Total 13F shares, excl. options
-
369,281,709
-
Shares change
-
+410,257
-
Total reported value, excl. options
-
$42,884,123,591
-
Value change
-
+$52,677,258
-
Put/Call ratio
-
106%
-
Number of buys
-
413
-
Number of sells
-
-424
-
Price
-
$116.18
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q1 2023
1,037 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q1 2023.
DEXCOM INC - Common Stock (DXCM) has 891 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 369,281,709 shares
of 392,193,323 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (44,112,133 shares), BlackRock Inc. (33,266,336 shares), BAILLIE GIFFORD & CO (17,157,499 shares), STATE STREET CORP (16,143,716 shares), SANDS CAPITAL MANAGEMENT, LLC (13,738,968 shares), FMR LLC (10,807,868 shares), JPMORGAN CHASE & CO (10,764,812 shares), Capital Research Global Investors (9,274,615 shares), GEODE CAPITAL MANAGEMENT, LLC (8,282,663 shares), and Nuveen Asset Management, LLC (7,857,922 shares).
This table shows the top 891 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.